
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1081 | 1050 | 1092 | 1211 | 1502 | 1651 |
Fund Return | 8.13% | 5.04% | 9.19% | 6.6% | 8.48% | 5.14% |
Place in category | 126 | 184 | 401 | 143 | 244 | 195 |
% in Category | 15 | 23 | 59 | 25 | 43 | 52 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BlackRock S&P 500 Index K | 17.68B | 1.43 | 12.50 | 12.94 | ||
BlackRock International Index Instl | 11.27B | 8.13 | 6.85 | 5.40 | ||
BlackRock International Index K | 11.27B | 8.12 | 6.92 | 5.46 | ||
BlackRock Equity Dividend Instl | 10.17B | 4.32 | 7.01 | 10.03 | ||
BlackRock Global Allocation Inv A | 8.1B | 2.59 | 3.95 | 5.14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 209.79B | 5.17 | 4.34 | 4.95 | ||
Vanguard Total Intl Stock Index Adm | 76.18B | 5.24 | 4.42 | 5.02 | ||
Fidelity International Index Inst | 55.99B | 8.06 | 6.85 | 5.50 | ||
Fidelity Series Global ex US Index | 52.88B | 6.06 | 4.88 | 4.92 | ||
Strategic Advisers International I | 47.55B | 7.61 | 6.47 | 6.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 2.15 | 530.5 | -3.44% | |
ASML Holding | NL0010273215 | 1.87 | 632.00 | -1.10% | |
Nestle | CH0038863350 | 1.48 | 88.60 | -2.10% | |
AstraZeneca | GB0009895292 | 1.36 | 11,480.0 | -3.06% | |
SAP | DE0007164600 | 1.34 | 238.650 | -1.47% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review